Clinical Trials Search

Department: Cardiology
Diagnosis: Cardiac - Hyperlipidemia
Sub-Investigator(s):
  • Kondareddy M.D., Shreekanth R.
  • Rudzinski M.D., Wojciech
Sponsor: Pfizer
Indentifier #: NCT01975389
Title: B1481038 PHASE 3 MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP EVALUATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF PF-04950615, IN REDUCING THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN HIGH RISK SUBJECTS
Department: Cardiology
Diagnosis: Cardiac - Hyperlipidemia
Sub-Investigator(s):
  • Kondareddy M.D., Shreekanth R.
  • Rudzinski M.D., Wojciech
Sponsor: Pfizer
Indentifier #: NCT01975376
Title: B1481022: Phase 3 Multi Center, Double Blind, Randomized, Placebo Controlled, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Pf-04950615, In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
Department: Cardiology
Diagnosis: Cardiac - Hyperlipidemia
Sub-Investigator(s):
  • Kondareddy M.D., Shreekanth R.
  • Rudzinski M.D., Wojciech
Sponsor: Pfizer
Indentifier #: NCT01968967
Title: B1481020, A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of PF-04950615 Following Subcutaneous Dosing for 52 Weeks in Subjects with Primary Hypercholesterolemia or Mixed Dyslipidemia, at High and Very High risk of Cardiovascular Events, Not Controlled with Lipid Lowering Therapy
Department: Cardiology
Diagnosis: Cardiac - Arrhythmia
Principal Investigator: Deshmukh MD, Pramod
Sub-Investigator(s):
  • Hackett CRNP, Vera
Sponsor: St. Jude Medical
Indentifier #: NCT01507987
Title: "St. Jude Medical Cardiac Lead Assessment Study"
Department: Oncology
Diagnosis: Oncology - General
Principal Investigator: Lash MD, Bradley
Sponsor: ALLIANCE
Indentifier #: NCT01841736
Title: Alliance A021202, Prospective Randomized Phase II Trial of Pazopanib (NSC # 737754, IND 75648) Versus Placebo in Patients With Progressive Carcinoid Tumors; ClinicalTrials.gov identifier: NCT01841736